Goldman Sachs Adds Weyerhaeuser (WY) to Conviction Buy List
Tweet Send to a FriendGet Alerts WY Hot Sheet
Price: $32.48 +1.60%
Rating Summary:
4 Buy, 8 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
4 Buy, 8 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade WY Now!
Goldman Sachs added Weyerhaeuser (NYSE: WY) to its Conviction Buy List with a price target of $25, suggesting 22% potential upside.
The firm cited: "(1) its leverage to the nascent US housing recovery, (2) the stock’s historical positive correlation to US housing starts, and lumber prices, which are both up well ahead of WY shares YTD, and (3) favorable wood products prices, which we believe are sustainable through 3Q, and we expect will drive consensus 2Q and 2012 estimates higher."
For an analyst ratings summary and ratings history on Weyerhaeuser click here. For more ratings news on Weyerhaeuser click here.
Shares of Weyerhaeuser closed at $20.45 yesterday, with a 52 week range of $14.82-$22.62.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm cited: "(1) its leverage to the nascent US housing recovery, (2) the stock’s historical positive correlation to US housing starts, and lumber prices, which are both up well ahead of WY shares YTD, and (3) favorable wood products prices, which we believe are sustainable through 3Q, and we expect will drive consensus 2Q and 2012 estimates higher."
For an analyst ratings summary and ratings history on Weyerhaeuser click here. For more ratings news on Weyerhaeuser click here.
Shares of Weyerhaeuser closed at $20.45 yesterday, with a 52 week range of $14.82-$22.62.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Goldman Sees Blockbuster Potential for Bristol-Myers Squibb's (BMY) Nivolumab (PD-1)
- KeyBanc Upgrades Cedar Shopping Centers (CDR) to Hold
- Wells Fargo Upgrades Rosetta Resources (ROSE) to Outperform, Shares Attractive
Create E-mail Alert Related Categories
UpgradesRelated Entities
Goldman Sachs Conviction Buy List, Goldman Sachs, Housing Starts
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
